How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future
Author:
Affiliation:
1. Department of Haematology, Oncology and Stem Cell Transplantation; Asklepios Hospital St. Georg; Hamburg Germany
2. Institute of Pathology; University Hospital Lausanne and University of Lausanne; Switzerland
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14473/fullpdf
Reference115 articles.
1. Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States;Adams;Journal of Clinical Oncology,2016
2. A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial;Advani;British Journal of Haematology,2016
3. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01;d'Amore;Journal of Clinical Oncology,2012
4. Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;d'Amore;Annals of Oncology,2015
5. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma;Ansell;Journal of Clinical Oncology,1997
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PD-1 blockade combined with decitabine to treat refractory peripheral T-cell lymphoma not otherwise specified: A case report and review of literature;Journal of Cancer Research and Therapeutics;2023-12
2. Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma: A multicenter phase II trial;Chinese Medical Journal;2023-10-13
3. Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy;British Journal of Haematology;2023-08-23
4. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop;Virchows Archiv;2023-07-27
5. PET/CT in Non-Hodgkin Lymphoma: An Update;Seminars in Nuclear Medicine;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3